1,361
Views
1
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Short Report

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis

ORCID Icon, , , &
Article: 2097818 | Received 01 Mar 2022, Accepted 01 Jul 2022, Published online: 11 Jul 2022